• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE2
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Migration (4003)
Patient Problems Stroke/CVA (1770); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/31/2023
Event Type  malfunction  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).This complaint is from a literature source and the following citation was reviewed: gu w, zhou g, aldiyarova a, liu t, zhang y, liu w, meng l, gu b, li m, su m, su c, liu a, wang w.Stent-assisted coiling of intracranial carotid ophthalmic segment aneurysm segment aneurysms: long-term follow-up from a single center.J interv med.2023 jul 31;6(3):116-120.Doi: 10.1016/j.Jimed.2023.07.004.Pmid: 37846339; pmcid: pmc10577061.Section d.4: the product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Section h.4: the device manufacture date is not known as the device lot number is not available / not reported.There is insufficient information within the text of this article to identify which devices(s) (cerenovus or non cerenovus) are associated with the reported adverse events.The complaint will be updated with any additional information received from performing follow-up activity with the corresponding author, and reportability will be reassessed if cerenovus devices are identified in association with any adverse events.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
This complaint is from a literature source and the following citation was reviewed: gu w, zhou g, aldiyarova a, liu t, zhang y, liu w, meng l, gu b, li m, su m, su c, liu a, wang w.Stent-assisted coiling of intracranial carotid ophthalmic segment aneurysm segment aneurysms: long-term follow-up from a single center.J interv med.2023 jul 31;6(3):116-120.Doi: 10.1016/j.Jimed.2023.07.004.Pmid: 37846339; pmcid: pmc10577061.Background and purpose: to evaluate the efficacy of stent-assisted coiling (sac) for the treatment of carotid ophthalmic segment aneurysm segment aneurysms (osas) of the internal carotid artery (ica) through detailed long-term follow-up of a large patient cohort.We retrospectively analyzed 88 consecutive patients with osas between (b)(6) 2009 and (b)(6) 2020 at our center.Angiographic results were evaluated using the modified raymond grading system and clinical outcomes were evaluated using the mrs scale.The primary endpoints were major aneurysm recurrence and poor clinical outcomes for at least 18 months of follow-up.The patients were asked to attend clinical follow-up assessments and possibly undergo dsa or mr via telephone.Cerenovus devices that were used in this study: qty unk: enterprise stents non-cerenovus devices that were also used in this study: qty unk: gdc detachable coils (stryker neurovascular); helicoil, microplex, and hydrocoil coils (microvention inc.); nexus and axium coils (ev3); neuroform stents (stryker neurovascular); , solataire ab stents (ev3); echelon 10 microcatheter (ev3); excelsior sl-10 microcatheter (stryker neurovascular).The article provides insufficient information to associate adverse event(s) to specific device manufacturer.Exact product quantities cannot be accurately determined as patients can experience more than one adverse event.Adverse event(s) and provided interventions not identified to be associated with specific device manufacturer's device: (b)(4): stent migration was encountered in three patients without clinical sequelae.(b)(4): post-interventional ischemic events developed in three patients after sac.(b)(4): coil migration (treatment failure).Treatments not listed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKENTERPRISE2
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
303552-689
MDR Report Key18608233
MDR Text Key335091336
Report Number3008114965-2024-00152
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/17/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AXIUM¿ EMBOLIC COILS (EV3); ECHELON 10¿ MICROCATHETER (MEDTRONIC); EXCELSIOR SL-10® MICROCATHETER (STRYKER); GDC¿ DETACHABLE COILS (STRYKER); HELICOIL¿ EMBOLIC COILS (MICROVENTION); HYDROCOIL¿ EMBOLIC COILS (MICROVENTION); MICROPLEX¿ EMBOLIC COILS (MICROVENTION); NEUROFORM¿ STENT SYSTEM (STRYKER); NEXUS¿ EMBOLIC COILS (EV3); SOLITAIRE AB¿ STENT SYSTEM (EV3)
-
-